| Jonathan Berkabile, APRN | |
|
500 N Rainbow Blvd Ste 203, Las Vegas, NV 89107-1084 | |
| (702) 259-1228 | |
| Not Available |
| Full Name | Jonathan Berkabile |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 500 N Rainbow Blvd Ste 203, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427776269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 858600 (Nevada) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 858600 (Nevada) | Primary |
| Entity Name | Shadow Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184795874 PECOS PAC ID: 2860667375 Enrollment ID: O20111212000888 |
News Archive
Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that targets the problematic protein, they say, it could help smooth treatment for patients with conditions ranging from prostate cancer to diabetes to HIV
Faced with today's unrelenting financial demands and quality of care challenges, leading hospitals and ambulatory surgery centers are turning to comparative healthcare benchmarks to help them improve operating room (OR) performance. Six of these trailblazers have been recognized by one such service, the OR Benchmarks® Collaborative (ORBC), as 2009 Top Performers that have used ORBC data to achieve significant results.
A University of Kentucky faculty member is a contributing author on a new study demonstrating a connection between a common solvent chemical and Parkinson's disease. Dr. Franca Cambi of the UK Kentucky Neuroscience Institute collaborated with researchers from across the U.S. on a paper recently published in the Annals of Neurology.
Biomerix Corporation today announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its proprietary biomaterial platform technology titled Reticulated elastomeric matrices, their manufacture and use in implantable devices.
NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay's NeutroPhase wound cleanser in a recent blog posting. The blog explains why NeutroPhase can play an important role in treating life-threatening necrotizing fasciitis, or 'flesh-eating' infections.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan Berkabile, APRN 10556 Mount Blackburn Ave, Las Vegas, NV 89166-5051 Ph: (702) 349-6395 | Jonathan Berkabile, APRN 500 N Rainbow Blvd Ste 203, Las Vegas, NV 89107-1084 Ph: (702) 259-1228 |
News Archive
Johns Hopkins and University of Alberta researchers have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. If a new drug can be found that targets the problematic protein, they say, it could help smooth treatment for patients with conditions ranging from prostate cancer to diabetes to HIV
Faced with today's unrelenting financial demands and quality of care challenges, leading hospitals and ambulatory surgery centers are turning to comparative healthcare benchmarks to help them improve operating room (OR) performance. Six of these trailblazers have been recognized by one such service, the OR Benchmarks® Collaborative (ORBC), as 2009 Top Performers that have used ORBC data to achieve significant results.
A University of Kentucky faculty member is a contributing author on a new study demonstrating a connection between a common solvent chemical and Parkinson's disease. Dr. Franca Cambi of the UK Kentucky Neuroscience Institute collaborated with researchers from across the U.S. on a paper recently published in the Annals of Neurology.
Biomerix Corporation today announced that the United States Patent and Trademark Office (USPTO) has granted a patent for its proprietary biomaterial platform technology titled Reticulated elastomeric matrices, their manufacture and use in implantable devices.
NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that WoundSource™ has highlighted NovaBay's NeutroPhase wound cleanser in a recent blog posting. The blog explains why NeutroPhase can play an important role in treating life-threatening necrotizing fasciitis, or 'flesh-eating' infections.
› Verified 4 days ago